Compare Mutual Funds
Risk
Very High
-
Rating
3.0
-
Min SIP Amount
₹100
-
Expense Ratio
2.12
-
NAV
₹29.72
-
Fund Started
04 Dec 2015
-
Fund Size
₹1239.57 Cr
-
Exit Load
Exit load of 0.25% if redeemed within 30 days.
-
1 Year
7.35%
-
3 Year
23.57%
-
5 Year
15.33%
-
Equity
99.10%
-
Cash
0.90%
-
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 9.31% |
Max Healthcare Institute Ltd. | 6.24% |
Abbott India Ltd. | 5.98% |
Divi's Laboratories Ltd. | 5.37% |
Healthcare Global Enterprises Ltd. | 5.14% |
Apollo Hospitals Enterprise Ltd. | 4.97% |
Cipla Ltd. | 4.69% |
Rainbow Children's Medicare Ltd. | 3.75% |
Mankind Pharma Ltd. | 3.38% |
Bayer CropScience Ltd. | 3.34% |
-
Name
-
-
Start Date
-
-
Description
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
-
Launch Date
04 Dec 2015
-
